Top 10 Pharmaceutical Companies in South Korea

User avatar placeholder
Written by Robert Gultig

21 November 2025

Introduction:

The pharmaceutical industry in South Korea has been rapidly growing in recent years, with a focus on innovation and research. According to the South Korean Ministry of Health and Welfare, the pharmaceutical market in South Korea reached a record high of $20.7 billion in 2020, with exports totaling $4.3 billion. This growth can be attributed to the increasing demand for healthcare products and services, as well as the government’s support for the industry.

Top 10 Pharmaceutical Companies in South Korea:

1. Samsung BioLogics
– Samsung BioLogics is one of the largest biopharmaceutical companies in South Korea, with a production volume of over 364,000 liters in 2020. The company specializes in the development and manufacturing of biopharmaceutical products, including antibodies and vaccines.

2. Celltrion
– Celltrion is a leading biopharmaceutical company in South Korea, with a market share of 7.5% in 2020. The company focuses on the production of biosimilars and innovative drugs, with exports reaching $1.2 billion in the same year.

3. Green Cross
– Green Cross is a well-established pharmaceutical company in South Korea, with a production volume of 1.78 billion units in 2020. The company is known for its high-quality vaccines and plasma-derived products, catering to both domestic and international markets.

4. Yuhan Corporation
– Yuhan Corporation is a key player in the South Korean pharmaceutical industry, with a market share of 4.2% in 2020. The company’s focus on research and development has led to the introduction of innovative drugs and healthcare solutions, contributing to its success in the market.

5. Hanmi Pharmaceutical
– Hanmi Pharmaceutical is a prominent pharmaceutical company in South Korea, with exports totaling $630 million in 2020. The company’s diverse product portfolio includes prescription drugs, over-the-counter medications, and medical devices, catering to a wide range of healthcare needs.

6. Daewoong Pharmaceutical
– Daewoong Pharmaceutical is a leading pharmaceutical company in South Korea, with a market share of 3.8% in 2020. The company’s strong presence in the domestic market, coupled with its growing international footprint, has solidified its position as a key player in the industry.

7. Chong Kun Dang Pharmaceutical
– Chong Kun Dang Pharmaceutical is a well-known pharmaceutical company in South Korea, with a production volume of 340 million units in 2020. The company’s commitment to innovation and quality has earned it a loyal customer base, both in South Korea and abroad.

8. Dong-A ST
– Dong-A ST is a reputable pharmaceutical company in South Korea, with exports reaching $510 million in 2020. The company’s focus on research and development, as well as strategic partnerships, has enabled it to expand its product portfolio and market reach over the years.

9. Bukwang Pharmaceutical
– Bukwang Pharmaceutical is a respected pharmaceutical company in South Korea, with a market share of 3.1% in 2020. The company’s dedication to producing high-quality generic drugs and specialty medications has positioned it as a key player in the industry.

10. Boryung Pharmaceutical
– Boryung Pharmaceutical is a well-established pharmaceutical company in South Korea, with a production volume of 280 million units in 2020. The company’s strong emphasis on research and development, as well as its commitment to quality and safety, has earned it a favorable reputation among healthcare professionals and consumers alike.

Insights:

The pharmaceutical industry in South Korea is poised for continued growth in the coming years, driven by factors such as increasing healthcare expenditure, a growing aging population, and advancements in technology. According to a report by Grand View Research, the South Korean pharmaceutical market is projected to reach $27.4 billion by 2028, with a CAGR of 5.1% from 2021 to 2028. This presents lucrative opportunities for pharmaceutical companies in South Korea to expand their product offerings, invest in research and development, and explore new markets both domestically and internationally. By staying abreast of market trends and consumer preferences, companies can position themselves for long-term success in this dynamic industry.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →